Catalyst Wire Dossier Catalyst Wire Dossier

SQ109

SQ109 · Sequella, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for SQ109, covering 2011-11-07 to 2017-09-20. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design [Phase 2]

See pricing